Researchers create two stem-cell lines from people with C9orf72-related ALS
Original source
Generation of two iPSC lines from ALS patients harboring C9orf72 hexanucleotide repeat expansions. (opens in a new tab)Compass summarised this from the study's abstract.
Study details
- Studied in
- Human
Population inferred from the title and abstract by Compass.
Related topics
Researchers created two induced pluripotent stem cell lines from two people with ALS who carried a C9orf72 repeat expansion. The cells showed expected markers of stem-cell identity, normal chromosome patterns and the ability to develop into three major cell types. The lines are intended for laboratory studies of C9orf72-related ALS.
Why this matters
These cell lines could help researchers study how C9orf72-related ALS develops and test research questions in the laboratory. They are a research resource, not a treatment, and the work does not show a benefit for people living with ALS.
Limitations and context
This was a laboratory study involving two cell lines from two people. The findings do not establish how well the cells model ALS or whether they will lead to an effective treatment.